MDG1:FRA
MediGene AG
0,017 €
arrow_upward
+3,61%(+0,00060) 1D
30. jun., 22:00:00 GMT +2 · EUR
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
Novice
Iz spletnih virov in novičarskih partnerjev
Simply Wall Street
·
pred 19 minutami
Why Peloton Interactive Fell Even As Profit Rose
The Globe and Mail
·
pred 59 minutami
Kaplan Fox Reminds Investors of Duolingo, Inc. (NASDAQ: DUOL) to a Securities Class Action Deadline - Contact the Firm Before December 7, 2026
Nasdaq
·
pred 13 urami
WISeSat.Space Holdings Corp. Rings the Opening Bell
Profil
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia